Apolipoprotein E and cholesterol affect neuronal calcium signalling: the possible relationship to beta-amyloid neurotoxicity

Biochem Biophys Res Commun. 1994 May 16;200(3):1185-92. doi: 10.1006/bbrc.1994.1576.

Abstract

Besides the neurotoxic properties of beta-amyloid (beta A4), apolipoprotein E polymorphism seems to play an important role in the pathogenesis of sporadic Alzheimer's disease (AD). The calcium amplifying effect of beta A25-35 (the neurotoxic sequence of beta A4) in dissociated mouse brain neurons and human lymphocytes was nearly abolished by cholesterol (100-500 mumol/l). This effect may be related to the membrane stabilizing properties of cholesterol which could be confirmed by measurements of membrane fluidity. ApoE did not affect the Ca2+ amplifying effect of beta A25-35, but amplified the neuronal Ca2+ response significantly in a very low concentration (100nmol/l). The findings suggest a possible link between AD pathology and ApoE polymorphism by the calcium amplifying effect of ApoE itself as well as by the modulation of beta A4 neurotoxicity by cholesterol.

MeSH terms

  • Amyloid beta-Peptides / toxicity*
  • Animals
  • Apolipoproteins A / pharmacology
  • Apolipoproteins E / pharmacology*
  • Calcium / physiology*
  • Cell Membrane / drug effects
  • Cholesterol / pharmacology*
  • Ethanol / pharmacology
  • Fluorescence Polarization
  • In Vitro Techniques
  • Membrane Fluidity / drug effects
  • Mice
  • Neurons / physiology*
  • Potassium Chloride / pharmacology
  • Signal Transduction

Substances

  • Amyloid beta-Peptides
  • Apolipoproteins A
  • Apolipoproteins E
  • Ethanol
  • Potassium Chloride
  • Cholesterol
  • Calcium